Role of nitric oxide in biological effects of
vascular endothelial growth factor

doi:10.1007/s11684-009-0062-1

Front. Med.

2009, Vol. 3

Issue (3) : 284-286 https://doi.org/10.1007/s11684-009-0062-1

Research articles

Role of nitric oxide in biological effects of vascular endothelial growth factor

Qigong LIU M D , Yan ZENG , Jiani LIU , Shan YE , Yongdong LI , Zaiying LU M D ,

Department of Internal Cardiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China;

Download: PDF(72 KB)
Export: BibTeX | EndNote | Reference Manager | ProCite | RefWorks

Abstract To evaluate the role of nitric oxide in the biological effects of vascular endothelial growth factor (VEGF) and the possible mechanism of VEGF, the in vitro cultured vascular endothelial cells of rabbit aorta were divided into control group, VEGF-treated group and VEGF+ N-nitro-L-arginine methyl ester (L-NAME)-treated group. The absorbance (A) value of vascular endothelial cells and the levels of prostaglandin (PGI₂), endothelin-1 (ET-1) and von Willebrand factor (vWF) in the supernatant were observed by water-soluble tetrazolium salt assay, radioimmunoassay and enzyme-linked immunosorbent assay. The A values and PGI₂ in VEGF-treated group and VEGF+L-NAME-treated group were higher than those in control group (P<0.05 and P<0.01). The ET-1 and vWF were significantly decreased in VEGF-treated group and VEGF+L-NAME-treated group compared with the control (P<0.05 and P<0.01). These results indicate that VEGF could promote the proliferation and secretion of PGI₂ and inhibit the secretion of ET-1 and vWF in vascular endothelial cells and that L-NAME could inhibit the effect of VEGF partially. Nitric oxide is an important mediator in the process of stimulating proliferation and regulating secretion of vascular endothelial cells by VEGF.

Keywords vascular endothelial growth factor nitric oxide N-nitro-L-arginine methyl ester vascular endothelial cells

Issue Date: 05 September 2009

Cite this article:

Yongdong LI,Qigong LIU M D,Jiani LIU, et al. Role of nitric oxide in biological effects of vascular endothelial growth factor[J]. Front. Med., 2009, 3(3): 284-286.

URL:

https://academic.hep.com.cn/fmd/EN/10.1007/s11684-009-0062-1
https://academic.hep.com.cn/fmd/EN/Y2009/V3/I3/284

	Kusumanto Y H, van Weel V, Mulder N H, Smit A J, van den Dungen J J, Hooymans J M, Sluiter W J, Tio R A, Quax P H, Gans R O, Dullaart R P, Hospers G A. Treatment with intramuscular vascular endothelial growthfactor gene compared with placebo for patients with diabetes mellitusand critical limb ischemia: a double-blind randomized trial. Hum Gene Ther, 2006, 17(6): 683―691 doi: 10.1089/hum.2006.17.683
	Qian H S, Liu P, Huw L Y, Orme A, Halks-Miller M, Hill S M, Jin F, Kretschmer P, Blasko E, Cashion L, Szymanski P, Vergona R, Harkins R, Yu J, Sessa W C, Dole W P, Rubanyi G M, Kauser K. Effective treatment of vascular endothelial growth factorrefractory hindlimb ischemia by a mutant endothelial nitric oxidesynthase gene. Gene Ther, 2006, 13(18): 1342―1350 doi: 10.1038/sj.gt.3302781
	Testa U, Pannitteri G, Condorelli G L. Vascular endothelial growth factors in cardiovascularmedicine. J Cardiovasc Med (Hagerstown), 2008, 9(12): 1190―1221
	Ylä-Herttuala S, Rissanen T T, Vajanto I, Hartikainen J. Vascular endothelial growth factors: biology and current status ofclinical applications in cardiovascular medicine. J Am Coll Cardiol, 2007, 49(10): 1015―1026 doi: 10.1016/j.jacc.2006.09.053
	Bougioukas I, Didilis V, Ypsilantis P, Giatromanolaki A, Sivridis E, Lialiaris T, Mikroulis D, Simopoulos C, Bougioukas G. Intramyocardial injection of low-dose basic fibroblastgrowth factor or vascular endothelial growth factor induces angiogenesisin the infarcted rabbit myocardium. CardiovascPathol, 2007, 16(2): 63―68 doi: 10.1016/j.carpath.2006.08.006
	Fuchs S, Dib N, Cohen B M, Okubagzi P, Diethrich E B, Campbell A, Macko J, Kessler P D, Rasmussen H S, Epstein S E, Kornowski R. A randomized, double-blind,placebo-controlled, multicenter, pilot study of the safety and feasibilityof catheter-based intramyocardial injection of AdVEGF121 in patientswith refractory advanced coronary artery disease. Catheter Cardiovasc Interv, 2006, 68(3): 372―378 doi: 10.1002/ccd.20859
	Stewart D J, Hilton J D, Arnold J M, Gregoire J, Rivard A, Archer S L, Charbonneau F, Cohen E, Curtis M, Buller C E, Mendelsohn F O, Dib N, Page P, Ducas J, Plante S, Sullivan J, Macko J, Rasmussen C, Kessler P D, Rasmussen H S. Angiogenic gene therapy in patients with nonrevascularizableischemic heart disease: a phase 2 randomized, controlled trial ofAdVEGF(121) (AdVEGF121) versus maximum medical treatment. Gene Ther, 2006, 13(21): 1503―1511 doi: 10.1038/sj.gt.3302802
	Liu Q G, Lu Z Y, Zhou H L, Yan J, Zhang W D. The mechanical study of vascular endothelialgrowth factor on the prevention of restenosis after angioplasty. J Tongji Med Univ, 2001, 21(3): 195―198
	Deiner C, Schwimmbeck P L, Koehler I S, Loddenkemper C, Noutsias M, Nikol S, Schultheiss H P, Ylä-Herttuala S, Pels K. Adventitial VEGF165 gene transfer preventslumen loss through induction of positive arterial remodeling afterPTCA in porcine coronary arteries. Atherosclerosis, 2006, 189(1): 123―132 doi: 10.1016/j.atherosclerosis.2005.12.008
	Sun Y M, Liu Q G, Zheng X Y. Effects of VEGF transduction through a Foley’scatheter on local vascular endothelial cell growth. Zhongguo Zuzhi Gongcheng Yanjiu Yu Linchuang Kangfu, 2008, 12(39): 7797―7800 (in Chinese)
	Hedman M, Hartikainen J, Syvänne M, Stjernvall J, Hedman A, Kivelä A, Vanninen E, Mussalo H, Kauppila E, Simula S, Närvänen O, Rantala A, Peuhkurinen K, Nieminen M S, Laakso M, Ylä-Herttuala S. Safety and feasibility of catheter-based local intracoronary vascularendothelial growth factor gene transfer in the prevention of postangioplastyand in-stent restenosis and in the treatment of chronic myocardialischemia: phase II results of the Kuopio Angiogenesis Trial (KAT). Circulation, 2003, 107(21): 2677―2683 doi: 10.1161/01.CIR.0000070540.80780.92
	Li H G, Forstermann U. Nitric oxide in the pathogenesisof vascular disease. J Pathol, 2000, 190(3): 244–254 doi: 10.1002/(SICI)1096-9896(200002)190:3<244::AID-PATH575>3.0.CO;2-8
	Hood J D, Meininger C J, Ziche M, Granger H J. VEGF upregulates ecNOS message, protein and NO production in humanendothelial cells. Am J Physiol, 1998, 274 (Heart Circ Physiol 43): H1054―1058
	Ziche M, Morbidelli L, Choudhuri R, Zhang H T, Donnini S, Granger H J, Bicknell R. Nitric oxide synthase liesdownstream from vascular endothelial growth factor-induced but notbasic fibroblast growth factor-induced angiogenesis. J Clin Invest, 1997, 99(11): 2625―2634 doi: 10.1172/JCI119451

[1]	Zhizhen LI, Fangping LI, Jianhong YE, Li YAN, Zuzhi FU. Effects of resistin on insulin signaling in endothelial cells[J]. Front Med Chin, 2009, 3(2): 136-140.
[2]	Qigong LIU, Honglian ZHOU, Yan ZENG, Shan YE, Jiani LIU, Zaiying LU. Mechanism of vascular endothelial growth factor on the prevention of restenosis after angioplasty[J]. Front Med Chin, 2009, 3(2): 177-180.
[3]	Geqing XIA, Chaoying WU. Expression of inducible nitric oxide synthase in trophoblasts and deciduas in early medical abortion[J]. Front Med Chin, 2009, 3(2): 216-219.
[4]	ZHAN Rong, YU Qinghong, HUANG Haobo. Effect of arsenic trioxide on proliferation and apoptosis of U266 cells and its relationship with the expression variation of VEGF[J]. Front. Med., 2008, 2(4): 356-360.
[5]	WANG Lin, LIU Yalan, XU Jianbo, TIAN Yuan, WU Heshui. Protective effect of N-acetylcysteine against lipopolysaccharide injury in hepatocytes of neonatal mice[J]. Front. Med., 2008, 2(2): 182-185.
[6]	TANG Zhongzhi, LI Junyao, YANG Jianhong. Relationship of endothelial nitric oxide synthase gene polymorphism with blood pressure, lipid profile and blood glucose level[J]. Front. Med., 2008, 2(2): 178-181.
[7]	LI Xin, CHENG Chun, CHEN Mengling, GAO Shangfeng, ZHAO Jian, NIU Shuqiong, SHEN Aiguo. Developmental expression of CAPON and Dexras1 in spinal cord of rats[J]. Front. Med., 2008, 2(1): 75-81.
[8]	WU Jun, LIN Jinchao, HE Zhaochu, OU Biru, GUO Haisen. Effect of hyperlipidemia on endothelial VCAM-1 expression and the protective role of fenofibrate[J]. Front. Med., 2007, 1(4): 356-358.

Viewed

Full text

Abstract

Cited

Shared

Discussed